EXPERT OPINION ON INVESTIGATIONAL DRUGS

EXPERT OPINION ON INVESTIGATIONAL DRUGS Journal

publication venue for

The time to offer treatments for COVID-19 2021
The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications. 14:1547-1559. 2005

International Standard Serial Number (ISSN)

1354-3784

Electronic International Standard Serial Number (EISSN)

1744-7658